Xenon Pharmaceuticals Inc. (XENE)

NASDAQ: XENE · Real-Time Price · USD

40.48

-0.52 (-1.27%)

At close: Nov 13, 2026, 4:00 PM EST

39.69

-0.79 (-1.95%)

After-hours: Nov 13, 2026, 7:51 PM EST

Xenon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,979	3,463	2,989	3,503	2,466	1,643
Market Cap Growth	29.75%	15.89%	-14.68%	42.03%	50.06%	196.62%
Enterprise Value	2,831	2,917	2,195	2,875	1,721	1,397
Last Close Price	40.48	44.82	39.20	46.06	39.43	31.24

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	21.65	21.65	21.65	21.65	21.65
PS Ratio	-	461.80	-	-	261.41	89.14
PB Ratio	3.47	5.95	3.96	3.78	3.42	2.99
P/TBV Ratio	3.47	5.95	3.96	3.78	3.42	2.99
PEG Ratio	-	2.51	2.51	2.51	2.51	2.51

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	-	388.87	-	-	182.44	75.77

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.02
Net Debt / Equity Ratio	-1.00	-0.99	-0.99	-0.99	-0.98	-0.99
Net Debt / EBITDA Ratio	2.48	1.56	2.69	4.34	5.56	6.96
Net Debt / FCF Ratio	3.21	2.07	4.04	5.87	6.84	7.60
Asset Turnover	-	0.01	-	-	0.01	0.05
Quick Ratio	21.01	13.17	17.66	23.43	26.12	38.72
Current Ratio	21.19	13.42	17.85	23.65	26.44	39.03
Return on Equity (ROE)	-50.27%	-51.76%	-27.85%	-22.12%	-19.72%	-21.87%
Return on Assets (ROA)	-32.18%	-32.58%	-19.80%	-15.57%	-12.17%	-12.97%
Return on Capital Employed (ROCE)	-40.30%	-63.10%	-36.60%	-22.80%	-17.70%	-14.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-11.55%	-9.99%	-7.84%	-5.21%	-5.08%	-4.80%
FCF Yield	-8.98%	-8.08%	-6.17%	-4.47%	-4.21%	-4.35%
Buyback Yield / Dilution	-16.36%	-1.75%	-16.45%	-10.48%	-38.77%	-21.09%

SEC Filings: 10-K · 10-Q